These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9699325)
41. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. Rodin DA; Bano G; Bland JM; Taylor K; Nussey SS Clin Endocrinol (Oxf); 1998 Jul; 49(1):91-9. PubMed ID: 9797852 [TBL] [Abstract][Full Text] [Related]
42. Glycosaminoglycan deposition in the acanthosis nigricans lesions of the polycystic ovary syndrome. Wortsman J; Matsuoka LY; Kupchella CE; Gavin JR; Dietrich JG Arch Intern Med; 1983 Jun; 143(6):1145-8. PubMed ID: 6344826 [TBL] [Abstract][Full Text] [Related]
43. GnRH Agonist Improves Hyperandrogenism in an Adolescent Girl With an Insulin Receptor Gene Mutation. Paprocki E; Barral RL; Vanden Brink H; Lujan M; Burgert TS J Endocr Soc; 2019 Jun; 3(6):1196-1200. PubMed ID: 31187077 [TBL] [Abstract][Full Text] [Related]
44. Medical therapy for the syndrome of familial virilization, insulin resistance, and acanthosis nigricans. Corenblum B; Baylis BW Fertil Steril; 1990 Mar; 53(3):421-5. PubMed ID: 2137793 [TBL] [Abstract][Full Text] [Related]
45. Ovarian pathology associated with insulin resistance and acanthosis nigricans. Annos T; Taymor ML Obstet Gynecol; 1981 Nov; 58(5):662-4. PubMed ID: 7301247 [TBL] [Abstract][Full Text] [Related]
46. A study of insulin resistance in subjects with acanthosis nigricans. Varthakavi PK; Patel KL; Wadhwa SL; Khopkar U; Sengupta RA; Merchant PC; Mehtalia SD; Nihalani KD J Assoc Physicians India; 2001 Jul; 49():705-12. PubMed ID: 11573555 [TBL] [Abstract][Full Text] [Related]
47. Insulin resistance with acanthosis nigricans and acral hypertrophy. Holdaway IM; Frengley PA; Graham FM; Wong M N Z Med J; 1984 May; 97(755):286-8. PubMed ID: 6587221 [TBL] [Abstract][Full Text] [Related]
51. Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans. Givens JR; Kurtz BR; Kitabchi AE; Bittle JB; Karas JG; Mitchell JA; Howes JF J Clin Endocrinol Metab; 1987 Feb; 64(2):377-82. PubMed ID: 3539980 [TBL] [Abstract][Full Text] [Related]
52. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism. Ozdemir S; Ozdemir M; Görkemli H; Kiyici A; Bodur S Acta Obstet Gynecol Scand; 2010; 89(2):199-204. PubMed ID: 19900078 [TBL] [Abstract][Full Text] [Related]
53. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist. Ruchhoft EA; Elkind-Hirsch KE; Malinak R Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611 [TBL] [Abstract][Full Text] [Related]
54. Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity. Conway GS; Jacobs HS Postgrad Med J; 1990 Jul; 66(777):536-8. PubMed ID: 2217009 [TBL] [Abstract][Full Text] [Related]